Baculovirus vectors elicit antigen-specific immune responses in mice

Journal of Virology

Volumn 78, Issue 16, 2004, Pages 8663-8672

  Facciabene, Andrea ^a   Aurisicchio, Luigi ^a   La Monica, Nicola ^a,b  

^a Istituto di Ricerche di Biologia Molecolare   (Italy)

^b IRBM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN E; GLYCOPROTEIN E2; INTERLEUKIN 6; PROTEIN ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOMEGALOVIRUS; DOSE RESPONSE; DOWNSTREAM PROCESSING; DRUG ADMINISTRATION ROUTE; EFFECTOR CELL; ENHANCER REGION; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; GENE CONSTRUCT; GENE THERAPY; HEPATITIS C VIRUS; IMMEDIATE EARLY GENE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STAINING; T LYMPHOCYTE ACTIVATION; TARGET CELL; VESICULAR STOMATITIS VIRUS; VIRUS ENVELOPE;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CARCINOEMBRYONIC ANTIGEN; FEMALE; GENETIC VECTORS; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; RECOMBINATION, GENETIC; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS;

EID: 3543150631     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.16.8663-8672.2004     Document Type: Article

References (43)

1. Abe, T., H. Takahashi, H. Hamazaki, N. Miyano-Kurosaki, Y. Matsuura, and H. Takaku. 2003. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J. Immunol. 171:1133-1139.
2. Airenne, K. J., M. O. Hiltunen, M. P. Turunen, O. H. Laitinen, M. S. Kulomaa, and Y. S. Herttuala. 2000. Baculovirus mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther. 7:1499-1504.
3. Aoki, H., Y. Sakoda, K. Jukuroki, A. Takada, H. Kida, and A. Fukusho. 1999. Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells. Vet. Microbiol. 68:197-207.
4. Barsoum, J. R. Brown, M. Mckee, and F. M. Boyce. 1997. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum. Gene Ther. 8:2011-2018.
5. Berinstein, N. L. 2002. Careinoembryonic antigen as a target for therapeutic anticancer vaccines: a review. J. Clin. Oncol. 20:2197-2207.
6. Boyce, F. M., and N. L. R. Bucher. 1996. Baculovirus mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. USA 93:2348-2352.
7. Bruna-Romero, O., G. Gonzàlez-Aseguinolaza, J. C. R. Hafalla, M. Tsuji, and R. S. Nussenweig. 2001. Complete, long lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proc. Natl. Acad. Sci. USA 98:11491-11496.
8. Casimiro, D. R., L. Chen, T. M. Fu, R. K. Evans, M. J. Aulfield, M. E. Davies, A. Tang, M. Chen, L. Huang, V. Harris, D. C. Freed, K. A. Wilson, S. Dubey, D. M. Zhu, D. Nawrocki, H. Mach, R. Troutman, L. Isopi, D. Williams, W. Hurni, Z. Xu, J. G. Smith, S. Wang, X. Liu, L. Guan, R. Long, W. Trigona, G. J. Heidecker, H. C. Perry, N. Persaud, T. J. Toner, Q. Su, X. Liang, R. Youil, M. Chastain, A. J. Bett, D. B. Volkin, E. A. Emini, and J. W. Shiver. 2003. Comparative immunogenicity in rhesus monkeys of DNA plasmid recombinant vaccinia virus and replication deficient adenovirus expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 77:6305-6313.
9. Casimiro, D., A. Tang, L. Chen, T. M. Fu, R. K. Evans, M. E. Davies, D. C. Freed, W. Hurni, J. M. Aste-Amezaga, L. Guam, R. Long, L. Huang, W. Harris, D. K. Nawrocki, H. Mach, R. T. Troutman, L. A. Isopi, K. K. Murthy, K. Rice, K. A. Wilson, D. B. Volkin, E. A. Emini, and J. W. Shiver. 2003. Vaccine induced immunity in baboons using DNA and replication-incompetent adenovirus type 5 vectors expressing a human immunodeficiency virus type 1 gag gene. J. Virol. 77:7663-7668.
10. Condreay, J. P., S. M. Witherspoon, W. C. Clay, and T. A. Kost. 1999. Transient and stable gene expression in mammalian cells transduced by a recombinant baculovirus vector. Proc. Natl. Acad. Sci. USA 96:127-132.
11. + cytotoxic T lymphocyte population. Int. Immunol. 14:31-37.
12. Fipaldini, C., B. Bellei, and N. La Monica. 1999. Expression of Hepatitis C virus cDNA in human hepatoma cell line mediated by a hybrid baculovirus-AAV vector. Virology 255:302-311.
13. Fitzgerald, J. C., G. P. Gao, A. Reyes-Sandoval, G. N. Pavlakis, Z. Q. Xiang, A. P. Wlazlo, W. Giles-Davis, J. M. Wilson, and H. C. J. Ertl. 2003. A simian replication defective adenoviral recombinant vaccine to HIV gag. J. Immunol. 170:1416-1422.
14. Gonzalo, R. M., G. Del Real, J. R. Rodriguez, D. Rodriguez, R. Heljasvaara, P. Lucas, V. Arraga, and M. Esteban. 2002. A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis. Vaccine 20:1226-1231.
15. Gronowski, A. M., D. M. Hilbert, K. C. F. Sheehan, G. Garotta, and R. D. Schreiber. 1999. Baculovirus stimulates antiviral effect in mammalian cells. J. Virol. 73:9944.
16. Hodge, J. W. 1996. Carcinoembryonic antigen as a target for cancer vaccines. Cancer Immunol. Immunother. 43:127-134.
17. Hofmann, C., and M. Strauss. 1998. Baculovirus mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther. 5:531-536.
18. Hofmann, C., V. Sandig, G. Jennings, M. Rudolph, P. Schlag, and M. Strauss. 1995. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. USA 92:10099-10103.
19. Ito, K., K. Ito, Shinhara, N., and S. Kato. 2003. DNA immunization via intramuscular and intradermal routes using gene gun provides different magnitudes and duration son immune response. Mol. Immunol. 39:847-854.
20. Kaneno, R., A. J. S. Duarte, and A. Borelli. 2002. Natural Killer activity in the experimental privational rickets. Immunol. Lett. 81:183-189.
21. Kwak, H., H. Horing, and H. L. Kaufman. 2003. Poxviruses as vectors for cancer immunotherapy. Curr. Opin. Drug Discov. Dev. 6:161-168.
22. Lauer, G. M., and B. D. Walker. 2001. Hepatitis C virus infection. N. Engl. J. Med. 345:41-52.
23. Lehtolainen, P., K. Tyynela, J. Kannasto, K. J. Airenne, and S. Yla-Herttuala. 2002. Baculovirus exhibits restricted cell type specificity in rat brain: a comparison of baculovirus-and adenovirus-mediated intracerebral gene transfer in vivo. Gene Ther. 9:1693-1699.
24. Lemiex, P. 2002. Technological advances to increase immunogenicity of DNA vaccines. Exp. Rev. Vaccines 1:85-93.
25. Liu, Q., and D. A. Muruve. 2003. Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10:935-940.
26. Luckow, V. A., and M. D. Summers. 1988. Signals important for high-level expression of foreing genes in Autographa californica nuclear polyhedrosis virus expression vectors. Virology 167:56.
27. Matsui, M., O. Moriya, and T. Akatsuka. 2003. Enhanced induction of hepatitis C virus specific cytotoxic T lymphocytes and protective efficacy in mice by vaccination followed by Adenovirus boosting in combination with the interleukin 12 expression plasmid. Vaccine 21:1629-1639.
28. Matsuura, Y., R. D. Possee, H. A. Overton, and D. H. L. Bishop. 1987. Baculovirus expression vector: the requirement for high level expression of proteins. Including glycoproteins. J. Gen. Virol. 68:1233.
29. Moore, A. C., W. P. Kong, B. K. Chakrabarti, and G. J. Nabel. 2002. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice. J. Virol. 76:243-250.
30. O'Reilly, D. R., L. K. Miller, and V. A. Luckow. 1992. Baculovirus expression vectors: a laboratory manual. Oxford University Press, Oxford, United Kingdom.
31. Pieroni, L., and N. La Monica. 2001. Towards the use of baculovirus as gene therapy vector. Curr. Opin. Mol. Ther. 3:465-467.
32. Pieroni, L., D. Maione, and N. La Monica. 2001. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum. Gene Ther. 12:871-881.
33. Sandig, V., C. Hofmann, S. Steinert, G. Jennings, P. Schlag, and M. Strauss. 1996. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum. Gene Ther. 7:1937-1945.
34. Sarkis, C., C. Serguera, S. Petres, D. Buichet, J. L. Rider, L. Edelman, and J. Mallet. 2000. Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc. Natl. Acad. Sci. USA 97:14638-14643.
35. Seong, Y. R., S. Choi, J.-S. Lim, C.-H. Lee, C.-K. Lee, and D. S. Im. 2001. Immunogenicity of E1E2 proteins of hepatitis C virus expressed by a recombinant adenovirus. Vaccine 19:2955-2964.
36. Shiver, J. W., T. M. Fu, L. Chen, D. R. Casimiro, M. E. Davies, R. K., Evans, Z. Q. Zhang, A. J. Simon, W. L. Trigona, S. A. dubey, L. Huang, W. A. Harris, R. S. Long, X. Liang, L. Handt, W. A. Schelif, Zhu, D. C. Freed, N. V. Persaud, L Guan, K. S. Punt, A. Tang, M. Chen, K. A. Wilson, K. B. Colling, G. J. Heldecker, W. R. Fernadez, H. C. Perry, J. G. Joyce, K. M. Grimm, J. C. Cook, P. M. Keller, D. S. Kresock, H. Mach, R. D. Troutman, L. A. Isopi, D. M. Williams, Z. Xu, K. E. Bohannon, D. B. Volkin, D. C. Montefiori, A. Miura, G. R., Krivulka, M. A. Lifton, M. J. Kuroda, J. E. Schmitz, N. L Letvin, M. J. Caulfield, A. J. Bett, R. Youil, D. C. Kaslow, and E. A. Emini. 2002. Replication incompetent adenoviral vector elicits effective anti- immunodeficiency-virus immunity. Nature 415:331-335.
37. Shoji, I., H. Aizaki, H. Tani, K. Ishihi, T. Chiba. I. Saito, T. Myamura, and Y. Matsuura. 1997. Efficient gene transfer into various mammalian cells, including non-hepatic cells, by baculovirus vectors. J. Gen. Virol. 78:2657-2664.
38. Srivastava, I. K., and M. A. Liu. 2003. Gene vaccines. Ann. Intern. Med. 138:550-559.
39. Tani, H., C. K. Limn, C. C. Yap, M. Onishi, M. Nozaki, Y. Nishimune, N. Okahashi, Y. Kitagawa, R. Watanabe, R. Mochizuki, K. Moriishi, and Y. Matsuura. 2003. In vitro and in vivo gene delivery by recombinant baculoviruses. J. Virol. 77:9799-9808.
40. Tani, H., M. Mishijima H. Ushijima, T. Miyamura, and Y. Matsuura. 2001. Characterization of cell-surface determinants important for baculovirus infection. Virology 279:343-353.
41. Wierzibicki, A., I. Kiszka, H. Kaneko, D. Kmieciak, T. J. Wasik, J. Gzyl, Y. Kaneko, and D. Kozbor. 2002. Immunization strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein. Vaccine 20:1295-1307.
42. Yap, C. C., K. Ishii, Y. Aoki, H. Aizaki, H. Tani, H. Shimuzu, Y. Ueno, T. Miyamura, and Y. Matsuura. 1997. A hybrid baculovirus-T7 RNA polymerase system for recovery of infectious virus from cDNA. Virology 231:192-200.
43. Zucchelli, S., S. Capone, E. Fattori, A. Folgori, A. Di Marco, D. Casimiro, A. J. Simon, R. Alufer, N. La Monica, R. Cortese, and A. Nicosia. 2000. Enhancing B- and T-cell immune response to hepatitis C virus E2 DNA vaccine intramuscular electrical gene transfer. J. Virol. 74:11598-11607.